ID   HT1080 EWSR1-FLI1-EGFP
AC   CVCL_C0RG
SY   HT1080_EWSR1-FLI1-EGFP
DR   cancercelllines; CVCL_C0RG
DR   GEO; GSM3585522
DR   GEO; GSM3585523
DR   GEO; GSM3585524
DR   GEO; GSM3585525
DR   Wikidata; Q112929756
RX   PubMed=30962207;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3508; EWSR1 (Note=EWSR1-FLI1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3749; FLI1 (Note=EWSR1-FLI1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 9
//
RX   PubMed=30962207; DOI=10.15252/embr.201845766; PMCID=PMC6500973;
RA   Linden M., Thomsen C., Grundevik P., Jonasson E., Andersson D.,
RA   Runnberg R., Dolatabadi S., Vannas C., Santamaria M.L.,
RA   Fagman H., Stahlberg A., Aman P.;
RT   "FET family fusion oncoproteins target the SWI/SNF chromatin
RT   remodeling complex.";
RL   EMBO Rep. 20:e45766.1-e45766.15(2019).
//